Affinity Asset Advisors’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-225,000
Closed -$29.6M 86
2020
Q4
$29.6M Buy
+225,000
New +$29.6M 15.69% 1